Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies

Antibody persistence following MeNZB vaccination of adults and children and response to a fourth dose in toddlers

(2011) C. Jackson et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Emerging resistance inNeisseria meningitidisandNeisseria gonorrhoeae - Retracted

(2011) Paola Stefanelli   Expert Review of Anti-Infective Therapy

Meningococcal serogroup B vaccines: will they live up to expectations?

(2011) Wendell D Zollinger et al.   Expert Review of Vaccines

Preclinical evidence for the potential of a bivalent fHBP vaccine to preventNeisseria meningitidisSerogroup C Disease

(2011) Shannon L. Harris et al.   Human vaccines & immunotherapeutics

From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak

(2011) François Caron et al.   LANCET INFECTIOUS DISEASES

Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans

(2011) Samba O. Sow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effectiveness of Serogroup C Meningococcal Conjugate Vaccine

(2011) Philippe De Wals et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Emergence of Epidemic Neisseria meningitidis Serogroup X Meningitis in Togo and Burkina Faso

(2011) Isabelle Delrieu et al.   PLoS One

Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and Neisserial heparin binding antigen

(2011) David M. Vu et al.   VACCINE

Serogroup C Neisseria meningitidis invasive infection: analysis of the possible vaccination strategies for a mass campaign

(2010) Elena Chiappini et al.   ACTA PAEDIATRICA

Pourquoi des recommandations de vaccination généralisée contre le méningocoque C en France ?

(2010) E. Grimprel   Antibiotiques

Adolescent immunisation: the next big thing?

(2010) Adam Finn et al.   ARCHIVES OF DISEASE IN CHILDHOOD

The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology

(2010) Vanessa N Racloz et al.   BMC INFECTIOUS DISEASES

Updated Postlicensure Surveillance of the Meningococcal C Conjugate Vaccine in England and Wales: Effectiveness, Validation of Serological Correlates of Protection, and Modeling Predictions of the Duration of Herd Immunity

(2010) H. Campbell et al.   Clinical and Vaccine Immunology

Antibody Persistence after Serogroup C Meningococcal Conjugate Immunization of United Kingdom Primary‐School Children in 1999–2000 and Response to a Booster: A Phase 4 Clinical Trial

(2010) K. P. Perrett et al.   CLINICAL INFECTIOUS DISEASES

Global prevailing and emerging pediatric pneumococcal serotypes

(2010) E David G McIntosh et al.   Expert Review of Vaccines

The genetic structure of Neisseria meningitidis populations in Cuba before and after the introduction of a serogroup BC vaccine

(2010) Yanet Climent et al.   INFECTION GENETICS AND EVOLUTION

Emergence of New VirulentNeisseria meningitidisSerogroup C Sequence Type 11 Isolates in France

(2010) Ala‐Eddine Deghmane et al.   JOURNAL OF INFECTIOUS DISEASES

Continued control of pneumococcal disease in the UK - the impact of vaccination

(2010) R. A. Gladstone et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: a systematic review

(2010) Ann Van den Bruel et al.   LANCET

Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease

(2010) Sonia Davila et al.   NATURE GENETICS

Meningococcal group A, C, Y and W-135 conjugate vaccine

(2010) Lee H. Harrison et al.   NATURE REVIEWS DRUG DISCOVERY

Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention

(2010) Marco Aurélio Palazzi Sáfadi et al.   NEUROLOGICAL RESEARCH

Immunity against Neisseria meningitidis Serogroup C in the Dutch Population before and after Introduction of the Meningococcal C Conjugate Vaccine

(2010) Richarda M. de Voer et al.   PLoS One

Invasive meningococcal disease and travel

(2010) Ziad A. Memish et al.   Journal of Infection and Public Health

Absence of Neisseria meningitidis Serogroup C-Specific Antibodies during the First Year of Life in The Netherlands: an Age Group at Risk?

(2009) R. M. de Voer et al.   Clinical and Vaccine Immunology

Fast Tracking the Vaccine Licensure Process to Control an Epidemic of Serogroup B Meningococcal Disease in New Zealand

(2009) Diana Lennon et al.   CLINICAL INFECTIOUS DISEASES

Changes inNeisseria meningitidisDisease Epidemiology in the United States, 1998–2007: Implications for Prevention of Meningococcal Disease

(2009) Amanda C. Cohn et al.   CLINICAL INFECTIOUS DISEASES

Safety and immunogenicity of an investigational quadrivalent meningococcal conjugate vaccine after one or two doses given to infants and toddlers

(2009) S. A. Halperin et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs

(2009) Caroline L Trotter et al.   Expert Review of Vaccines

Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines

(2009) Daniel J. Isaacman et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Increasing Adolescent Vaccination: Barriers and Strategies in the Context of Policy, Legal, and Financial Issues

(2009) Carol A. Ford et al.   JOURNAL OF ADOLESCENT HEALTH

Students' attitudes to the communications employed during an outbreak of meningococcal disease in a UK school: a qualitative study

(2009) D. Taylor-Robinson et al.   JOURNAL OF PUBLIC HEALTH

MODERN TRENDS IN MORTALITY FROM MENINGOCOCCAL DISEASE IN AUSTRALIA

(2009) Daniel Simpkins et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

The Impact of Childhood Meningococcal Serogroup C Conjugate Vaccine Programs in Canada

(2009) Julie A. Bettinger et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Continued Impact of Pneumococcal Conjugate Vaccine on Carriage in Young Children

(2009) S. S. Huang et al.   PEDIATRICS

Global epidemiology of meningococcal disease

(2009) Lee H. Harrison et al.   VACCINE

Phase II meningococcal B vesicle vaccine trial in New Zealand infants

(2008) C Jackson et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Economics of an Adolescent Meningococcal Conjugate Vaccination Catch-up Campaign in the United States

(2008) Ismael R. Ortega Sanchez et al.   CLINICAL INFECTIOUS DISEASES

Increased Detection of Meningococcal Infections in California Using a Polymerase Chain Reaction Assay

(2008) Kate C. Cummings et al.   CLINICAL INFECTIOUS DISEASES

Outbreak of meningococcal disease in and around New Delhi, India, 2005–2006: a report from a tertiary care hospital

(2008) D. NAIR et al.   EPIDEMIOLOGY AND INFECTION

Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years

(2008) Y. Galloway et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

(2008) Martin C. J. Maiden et al.   JOURNAL OF INFECTIOUS DISEASES

Recent epidemiological changes in meningococcal disease may be due to the displacement of serogroup A by serogroup C in Hefei city, China

(2008) J D. Ni et al.   POSTGRADUATE MEDICAL JOURNAL